Partner Content Partner Content M3 announces the acquisition of Vidal Group M3 is strengthening and growing its global operations
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
Views & Analysis Implementing cloud marketing technology Sanofi Pasteur MSD’s journey to digital has helped sales rep engagement, as well as compliant content creation and distribution.
Views & Analysis Artificial intelligence: the way ahead for pharma What has been its impact on the pharma and healthcare sectors?
Views & Analysis Blockchain protocol: applications in healthcare System promises improvements in clinical trial verification and anti-counterfeiting.
Views & Analysis Rare diseases and orphan drugs need digital innovation mHealth tech can provide longer-term monitoring for clinical trials.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
